Scholarlink

Background <p>Percutaneous renal biopsy (PRB) is an essential diagnostic procedure for kidney diseases, yet postbiopsy perirenal hematoma and pain remain frequent complications. Vitamin C has emerging evidence supporting its role in reducing perioperative bleeding and pain, but its efficacy in the context of PRB is unknown.</p> Methods <p>This single-center, prospective, open-label, randomized controlled trial enrolled 710 adults with chronic kidney disease (CKD) scheduled for an ultrasound-guided native kidney biopsy. Participants were randomly assigned (1:1) to receive perioperative intravenous vitamin C (20 mg/kg at 6 h before and 18 h after biopsy) or standard care alone. The primary outcomes were the area of perirenal hematoma on renal ultrasound at 24 h and self-reported pain intensity (Visual Analogue Scale, VAS) at 2, 12, and 24 h post-biopsy.</p> Results <p>All 710 randomized participants were included in the analysis. The adjusted mean difference in hematoma area at 24 h was 4.44 mm² (95% CI, −52.31 to 61.18; P = 0.878). After multiple testing correction, there were no significant differences in the primary pain outcome (VAS scores) between groups at any time point; however, an exploratory analysis of pain severity categories indicated a less favorable distribution in the Vitamin C group at 12 h (P for trend =0.033). The incidence of any perirenal hematoma was 56.3% in the vitamin C group versus 50.1% in the control group (risk ratio, 1.12; 95% CI, 0.98–1.29; P = 0.098). Rates of other bleeding complications and adverse events were low and comparable between groups.</p> Conclusions <p>In CKD patients undergoing PRB, perioperative intravenous vitamin C did not reduce the size of perirenal hematoma, alleviate postbiopsy pain, or decrease the incidence of bleeding complications within 24 h. These findings do not support the routine use of vitamin C for preventing complications after kidney biopsy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effect of Vitamin C on bleeding and pain after kidney biopsy: a randomized controlled trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月3日

查看全文
  • Jipeng Li,
  • Fang Zhao,
  • Rui Lu,
  • Yang Zha,
  • Fengpei Chang,
  • Xiayin Li,
  • Jingli Gao,
  • Xi Shen,
  • Qing Jia,
  • Jing Zhao,
  • Xiaolan Che,
  • Xiaomeng Xu,
  • Mengting Wu,
  • Hongyi Zhang,
  • Yuting Zhang,
  • Ye Chen,
  • Xinrui Tan,
  • Lijie He

摘要

Background

Percutaneous renal biopsy (PRB) is an essential diagnostic procedure for kidney diseases, yet postbiopsy perirenal hematoma and pain remain frequent complications. Vitamin C has emerging evidence supporting its role in reducing perioperative bleeding and pain, but its efficacy in the context of PRB is unknown.

Methods

This single-center, prospective, open-label, randomized controlled trial enrolled 710 adults with chronic kidney disease (CKD) scheduled for an ultrasound-guided native kidney biopsy. Participants were randomly assigned (1:1) to receive perioperative intravenous vitamin C (20 mg/kg at 6 h before and 18 h after biopsy) or standard care alone. The primary outcomes were the area of perirenal hematoma on renal ultrasound at 24 h and self-reported pain intensity (Visual Analogue Scale, VAS) at 2, 12, and 24 h post-biopsy.

Results

All 710 randomized participants were included in the analysis. The adjusted mean difference in hematoma area at 24 h was 4.44 mm² (95% CI, −52.31 to 61.18; P = 0.878). After multiple testing correction, there were no significant differences in the primary pain outcome (VAS scores) between groups at any time point; however, an exploratory analysis of pain severity categories indicated a less favorable distribution in the Vitamin C group at 12 h (P for trend =0.033). The incidence of any perirenal hematoma was 56.3% in the vitamin C group versus 50.1% in the control group (risk ratio, 1.12; 95% CI, 0.98–1.29; P = 0.098). Rates of other bleeding complications and adverse events were low and comparable between groups.

Conclusions

In CKD patients undergoing PRB, perioperative intravenous vitamin C did not reduce the size of perirenal hematoma, alleviate postbiopsy pain, or decrease the incidence of bleeding complications within 24 h. These findings do not support the routine use of vitamin C for preventing complications after kidney biopsy.